SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-14-003181
Filing Date
2014-03-19
Accepted
2014-03-19 14:55:03
Documents
11

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2392477
2 GRAPHIC g582812g79g72.jpg GRAPHIC 11521
3 GRAPHIC g582812g00s17.jpg GRAPHIC 20279
4 GRAPHIC g582812g10p01.jpg GRAPHIC 8074
5 GRAPHIC g582812g15y81.jpg GRAPHIC 63102
6 GRAPHIC g582812g18t78.jpg GRAPHIC 17391
7 GRAPHIC g582812g19o69.jpg GRAPHIC 19440
8 GRAPHIC g582812g44n07.jpg GRAPHIC 10639
9 GRAPHIC g582812g70j23.jpg GRAPHIC 24865
10 GRAPHIC g582812g76k38.jpg GRAPHIC 27754
11 filename11.htm COVER 28020
  Complete submission text file 0000950123-14-003181.txt   2702659
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-00290 | Film No.: 14703793
SIC: 2834 Pharmaceutical Preparations